ATXI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting...

Stats
Today's Volume	320 639
Average Volume	1.57M
Market Cap	5.75M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.120 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.130
ATR14	$0.00100 (0.78%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Fortress Biotech, Inc.	Buy	413 507	COMMON STOCK, PAR VALUE $0.0001
2024-01-02	Fortress Biotech, Inc.	Buy	2 101 496	COMMON STOCK, PAR VALUE $0.0001
2023-12-11	Davidow Robert L	Sell	264 000	Common Stock
2023-12-11	Davidow Robert L	Sell	126 000	Common Stock
2023-12-11	Davidow Robert L	Sell	128 000	Common Stock

INSIDER POWER
72.54
Last 83 transactions
Buy: 6 766 707 \| Sell: 1 021 576

Volume Correlation

Long: -0.02 (neutral)

Short: 0.94 (very strong)

Signal:(47.461) Expect same movement, but be aware

Avenue Therapeutics Inc Correlation

10 Most Positive Correlations
GETVV	0.801

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avenue Therapeutics Inc Correlation - Currency/Commodity

0.00
( neutral )

-0.60
( weak negative )

Avenue Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.980

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0.0250

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0.0648

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.520

Financial Reports:

No articles found.

Avenue Therapeutics Inc

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.